Thai PBS Thai PBS
All eyes on China’s Sinovac – Thailand’s vaccine choice for emergency

All eyes on China’s Sinovac – Thailand’s vaccine choice for emergency

23 Sept 03:10 Key points summarised by AI
  • Thailand's emergency vaccination program heavily relies on China's Sinovac (CoronaVac), prompting public scrutiny over its efficacy and widespread administration.
  • Clinical trials show varied efficacy for CoronaVac against symptomatic infection (50.4% to 83.5%) and higher protection against severe cases, yet it remains unrecognized by the EU and WHO for international travel.
  • Beyond Sinovac and locally produced AstraZeneca, Thailand is actively diversifying its vaccine portfolio, with Johnson & Johnson and Moderna registered, and negotiations underway for Pfizer and Sputnik V.
  • Public interest in 'walk-in vaccinations' has been met with significant confusion due to contradictory government messages, complicating the national inoculation drive.
Read full article
News 1/1
Skip > Skip >